235 related articles for article (PubMed ID: 30641171)
1. Plasma omentin levels are associated with vascular endothelial function in patients with type 2 diabetes at elevated cardiovascular risk.
Hayashi M; Morioka T; Hatamori M; Kakutani Y; Yamazaki Y; Kurajoh M; Motoyama K; Mori K; Fukumoto S; Shioi A; Shoji T; Emoto M; Inaba M
Diabetes Res Clin Pract; 2019 Feb; 148():160-168. PubMed ID: 30641171
[TBL] [Abstract][Full Text] [Related]
2. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes.
Yoo HJ; Hwang SY; Hong HC; Choi HY; Yang SJ; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH
Cardiovasc Diabetol; 2011 Nov; 10():103. PubMed ID: 22108456
[TBL] [Abstract][Full Text] [Related]
3. Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study.
Nishimura M; Morioka T; Hayashi M; Kakutani Y; Yamazaki Y; Kurajoh M; Mori K; Fukumoto S; Shioi A; Shoji T; Inaba M; Emoto M
Cardiovasc Diabetol; 2019 Dec; 18(1):167. PubMed ID: 31805941
[TBL] [Abstract][Full Text] [Related]
4. Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease.
Biscetti F; Nardella E; Bonadia N; Angelini F; Pitocco D; Santoliquido A; Filipponi M; Landolfi R; Flex A
Cardiovasc Diabetol; 2019 Jun; 18(1):74. PubMed ID: 31167666
[TBL] [Abstract][Full Text] [Related]
5. Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus.
Yoo HJ; Hwang SY; Hong HC; Choi HY; Yang SJ; Lee KW; Nam MS; Park YS; Woo JT; Kim YS; Choi KM; Baik SH
Endocrine; 2013 Dec; 44(3):680-7. PubMed ID: 23532633
[TBL] [Abstract][Full Text] [Related]
6. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease.
El-Mesallamy HO; El-Derany MO; Hamdy NM
Diabet Med; 2011 Oct; 28(10):1194-200. PubMed ID: 21668495
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma advanced oxidation protein products is an early marker of endothelial dysfunction in type 2 diabetes patients without albuminuria 2.
Liang M; Wang J; Xie C; Yang Y; Tian JW; Xue YM; Hou FF
J Diabetes; 2014 Sep; 6(5):417-26. PubMed ID: 24506465
[TBL] [Abstract][Full Text] [Related]
8. Circulatory Omentin-1 levels but not genetic variants influence the pathophysiology of Type 2 diabetes.
Rathwa N; Patel R; Pramanik Palit S; Jadeja SD; Narwaria M; Ramachandran AV; Begum R
Cytokine; 2019 Jul; 119():144-151. PubMed ID: 30909150
[TBL] [Abstract][Full Text] [Related]
9. Higher circulating omentin is associated with increased risk of primary cardiovascular events in individuals with diabetes.
Niersmann C; Carstensen-Kirberg M; Maalmi H; Holleczek B; Roden M; Brenner H; Herder C; Schöttker B
Diabetologia; 2020 Feb; 63(2):410-418. PubMed ID: 31705160
[TBL] [Abstract][Full Text] [Related]
10. Omentin: linking metabolic syndrome and cardiovascular disease.
Zhou JY; Chan L; Zhou SW
Curr Vasc Pharmacol; 2014 Jan; 12(1):136-43. PubMed ID: 22724476
[TBL] [Abstract][Full Text] [Related]
11. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy.
Senthilkumar GP; Anithalekshmi MS; Yasir M; Parameswaran S; Packirisamy RM; Bobby Z
Diabetes Metab Syndr; 2018; 12(1):23-26. PubMed ID: 28864059
[TBL] [Abstract][Full Text] [Related]
12. Circulating omentin as a novel biomarker of endothelial dysfunction.
Moreno-Navarrete JM; Ortega F; Castro A; Sabater M; Ricart W; Fernández-Real JM
Obesity (Silver Spring); 2011 Aug; 19(8):1552-9. PubMed ID: 21293447
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin.
Yilmaz MI; Saglam M; Qureshi AR; Carrero JJ; Caglar K; Eyileten T; Sonmez A; Cakir E; Oguz Y; Vural A; Yenicesu M; Stenvinkel P; Lindholm B; Axelsson J
Nephrol Dial Transplant; 2008 May; 23(5):1621-7. PubMed ID: 18175782
[TBL] [Abstract][Full Text] [Related]
14. Assessment of heart rate variability (HRV) in subjects with type 2 diabetes mellitus with and without diabetic foot: correlations with endothelial dysfunction indices and markers of adipo-inflammatory dysfunction.
Tuttolomondo A; Del Cuore A; La Malfa A; Casuccio A; Daidone M; Maida CD; Di Raimondo D; Di Chiara T; Puleo MG; Norrito R; Guercio G; Pinto A
Cardiovasc Diabetol; 2021 Jul; 20(1):142. PubMed ID: 34261479
[TBL] [Abstract][Full Text] [Related]
15. Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study.
Herder C; Kannenberg JM; Niersmann C; Huth C; Carstensen-Kirberg M; Wittenbecher C; Schulze M; Blüher M; Rathmann W; Peters A; Roden M; Meisinger C; Thorand B
Eur J Endocrinol; 2017 Oct; 177(4):277-286. PubMed ID: 28679518
[TBL] [Abstract][Full Text] [Related]
16. Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus.
Yan P; Liu D; Long M; Ren Y; Pang J; Li R
Exp Clin Endocrinol Diabetes; 2011 Apr; 119(4):257-63. PubMed ID: 21374544
[TBL] [Abstract][Full Text] [Related]
17. Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study.
Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
Cardiovasc Diabetol; 2015 Oct; 14():140. PubMed ID: 26466574
[TBL] [Abstract][Full Text] [Related]
18. Serum omentin-1 levels as a possible risk factor of mortality in patients with diabetes on haemodialysis.
Kocijancic M; Vujicic B; Racki S; Cubranic Z; Zaputovic L; Dvornik S
Diabetes Res Clin Pract; 2015 Oct; 110(1):44-50. PubMed ID: 26293449
[TBL] [Abstract][Full Text] [Related]
19. Low serum omentin levels in the elderly population with Type 2 diabetes and polyneuropathy.
Herder C; Bongaerts BW; Ouwens DM; Rathmann W; Heier M; Carstensen-Kirberg M; Koenig W; Thorand B; Roden M; Meisinger C; Ziegler D;
Diabet Med; 2015 Nov; 32(11):1479-83. PubMed ID: 26094489
[TBL] [Abstract][Full Text] [Related]
20. Serum omentin-1 levels in diabetic and nondiabetic patients with chronic kidney disease.
Tekce H; Tekce BK; Aktas G; Alcelik A; Sengul E
Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):451-6. PubMed ID: 24918534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
